Are ‘Super-Enhancers’ the Future of Cancer Therapy?

Nancy Simonian, MD, CEO, Syros Pharmaceuticals details the research of Richard A. Young of the Whitehead Institute and his discovery of super-enhancers, large groups of transcriptional enhancers that drive expression of genes that define cell identity. The research, which has revealed many previously unknown oncogenic drivers, may be important for future cancer therapies.


22034 Total Views 4 Views Today

The Doctor's Channel

Take a bite from the adults' table. The Doctor’s Channel is the world’s leading video site for physicians. Get the latest news in clinical medicine, disease resource centers, CME programs, and Doc Life, all in under 3 mins or less.